A leading Turkish company in the production of medicines and vaccines, Turk Ilac, has set up a joint action plan with Interglobe IEG to build seven parenteral solution production plants in Africa. The production of the new plants will start with Benin, Togo, Angola, Niger and Congo-Brazzaville. In his words, The Chairman of Turk Ilaç, Mehmet Berat Battal said that the development of these seven production units across Africa is of vital importance for the sustainable development not only of the African people, but also for the global economy as a whole.   DFIs can boost agribusiness, infrastructure growth-BoI boss     2023 elections: Experts fear economy may collapse     Omiyi is new Seplat Energy chairman   “Turk Ilac’s action plan for the continent is to focus on four key areas: Investment in the pharmaceutical sector in Africa to ensure health and wellbeing for all; Transfer of advanced technology and best practices in Africa; Promotion of women’s employment; and Research and development.” At the signing of the action plan, Interglobe IEG Executive Chairman, Bunmi Jinadu said, “It is quite concerning that trade between African countries only accounts for 18% of global trade.” We believe that supporting the development of a sustainable pharmaceutical industry in Africa is a powerful contribution to achieving the SDGs. The AfCFTA will help accelerate and deepen trade within Africa and between Africa and other continents, it will be a catalyst for sustainable development to Africa for generations to come.”